Brown Advisory Inc. Sells 113,682 Shares of Avantor, Inc. (NYSE:AVTR)

Brown Advisory Inc. cut its position in Avantor, Inc. (NYSE:AVTR) by 87.6% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 16,070 shares of the company’s stock after selling 113,682 shares during the quarter. Brown Advisory Inc.’s holdings in Avantor were worth $260,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Tidal Investments LLC boosted its stake in Avantor by 59.6% in the 4th quarter. Tidal Investments LLC now owns 18,869 shares of the company’s stock valued at $398,000 after purchasing an additional 7,048 shares during the period. Rhenman & Partners Asset Management AB lifted its position in shares of Avantor by 40.5% during the 4th quarter. Rhenman & Partners Asset Management AB now owns 61,826 shares of the company’s stock valued at $1,303,000 after acquiring an additional 17,826 shares during the period. Brown Brothers Harriman & Co. lifted its position in shares of Avantor by 0.3% during the 4th quarter. Brown Brothers Harriman & Co. now owns 2,921,765 shares of the company’s stock valued at $61,562,000 after acquiring an additional 7,800 shares during the period. Proficio Capital Partners LLC acquired a new stake in shares of Avantor during the 4th quarter worth $695,000. Finally, Pictet Asset Management Holding SA increased its position in shares of Avantor by 2.8% in the fourth quarter. Pictet Asset Management Holding SA now owns 6,560,792 shares of the company’s stock worth $138,236,000 after purchasing an additional 179,894 shares during the period. 95.08% of the stock is currently owned by institutional investors.

Insider Transactions at Avantor

In other news, Director Gregory L. Summe bought 30,000 shares of the stock in a transaction on Friday, May 23rd. The stock was acquired at an average price of $12.50 per share, with a total value of $375,000.00. Following the acquisition, the director directly owned 100,000 shares in the company, valued at approximately $1,250,000. This trade represents a 42.86% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Joseph R. Massaro bought 8,100 shares of the stock in a transaction on Tuesday, April 29th. The stock was purchased at an average cost of $12.30 per share, with a total value of $99,630.00. Following the acquisition, the director owned 35,038 shares in the company, valued at approximately $430,967.40. This represents a 30.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last ninety days, insiders acquired 83,100 shares of company stock valued at $1,027,630. Insiders own 1.20% of the company’s stock.

Avantor Price Performance

Shares of AVTR stock opened at $12.88 on Thursday. The company has a quick ratio of 0.75, a current ratio of 1.12 and a debt-to-equity ratio of 0.54. Avantor, Inc. has a twelve month low of $11.82 and a twelve month high of $28.00. The company has a market cap of $8.77 billion, a P/E ratio of 12.38, a P/E/G ratio of 1.36 and a beta of 1.05. The business has a fifty day simple moving average of $13.26 and a 200 day simple moving average of $16.17.

Avantor (NYSE:AVTR) last announced its quarterly earnings data on Friday, April 25th. The company reported $0.23 earnings per share for the quarter, hitting the consensus estimate of $0.23. Avantor had a return on equity of 11.93% and a net margin of 10.70%. The business had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.61 billion. During the same period in the prior year, the company earned $0.22 EPS. Avantor’s revenue for the quarter was down 5.9% on a year-over-year basis. On average, sell-side analysts forecast that Avantor, Inc. will post 1.06 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts recently commented on the company. Morgan Stanley downgraded Avantor from an “overweight” rating to an “equal weight” rating in a research note on Tuesday, April 29th. The Goldman Sachs Group downgraded Avantor from a “buy” rating to a “neutral” rating and dropped their price target for the company from $23.00 to $14.00 in a research note on Tuesday, April 29th. Robert W. Baird dropped their price target on Avantor from $21.00 to $17.00 and set an “outperform” rating for the company in a research note on Monday, April 28th. Barclays dropped their price target on Avantor from $18.00 to $15.00 and set an “overweight” rating for the company in a research note on Monday, April 28th. Finally, Royal Bank Of Canada dropped their price target on Avantor from $24.00 to $20.00 and set an “outperform” rating for the company in a research note on Monday, April 28th. Seven research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat.com, Avantor has a consensus rating of “Hold” and a consensus price target of $18.14.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.